Abstract:Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson’s disease (PD), which is the leading neurodegenerative movement disorder characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). However, whether LRRK2 mutations cause PD and degeneration of DA neurons a toxic gain-of-function or a loss-of-function mechanism is unresolved and has pivotal implications for LRRK2-based PD therapies. In this study, we investigate whether LRRK2 and its functional homologue LRRK1 play an essential, intrinsic role in DA neuron survival through the development of DA neuron-specific conditional double knockout (cDKO) mice. We first generated and characterized floxed and mice and then confirmed that germline deletions of the floxed and alleles result in null mutations, as evidenced by the absence of and mRNA and protein in the respective homozygous deleted mutant mice. We further examined the specificity of Cre-mediated recombination driven by the - ( ) knockin (KI) allele using a GFP reporter line and confirmed that -mediated recombination is restricted to DA neurons in the SNpc. Crossing these validated floxed and mice with KI mice, we then generated DA neuron-restricted cDKO mice and further showed that levels of LRRK1 and LRRK2 are reduced in dissected ventral midbrains of cDKO mice. While DA neuron-restricted cDKO mice of both sexes exhibit normal mortality and body weight, they develop age-dependent loss of DA neurons in the SNpc, as demonstrated by the progressive reduction of DA neurons in the SNpc of cDKO mice at the ages of 20 and 24 months but the unaffected number of DA neurons at the age of 15 months. Moreover, DA neurodegeneration is accompanied with increases of apoptosis and elevated microgliosis in the SNpc as well as decreases of DA terminals in the striatum, and is preceded by impaired motor coordination. Taken together, these findings provide the unequivocal evidence for the importance of LRRK in DA neurons and raise the possibility that LRRK2 mutations may impair its protection of DA neurons, leading to DA neurodegeneration in PD.

The Wd40 Domain Is Required For Lrrk2 Neurotoxicity

How Parkinson's Disease-Related Mutations Disrupt the Dimerization of WD40 Domain in LRRK2: a Comparative Molecular Dynamics Simulation Study

Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles Through Protein Interactions Mediated by Its C-Terminal WD40 Domain

15-Lipoxygenase-Mediated Lipid Peroxidation Regulates LRRK2 Kinase Activity

Cell-autonomous role of leucine-rich repeat kinase in the protection of dopaminergic neuron survival

Structural Model of the Dimeric Parkinson'S Protein Lrrk2 Reveals A Compact Architecture Involving Distant Interdomain Contacts

Leucine-Rich Repeat Kinases

Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism

Roles of the Drosophila Lrrk2 Homolog in Rab7-Dependent Lysosomal Positioning

LRRK2, a puzzling protein: Insights into Parkinson's disease pathogenesis

Electron Microscopy Structure of Dimeric Lrrk2 Reveals A Structural and Regulatory Role of the Cor Domain

Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival

14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state

Membrane remodeling properties of the Parkinson's disease protein LRRK2

Phosphorylation-dependent 14-3-3 Binding to LRRK2 is Impaired by Common Mutations of Familial Parkinson's Disease.

Two Helices Control the Dynamic Crosstalk Between the Catalytic Domains of LRRK2

The Role of the LRRK2 Gene in Parkinsonism

Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death

LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status

Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2

RedOx regulation of LRRK2 kinase activity by active site cysteines